The results of these bioavailability studies indicate that the test formulation of losartan/hydrochlorothiazide @ + @ mg ( EPR@ ) tablets is bioequivalent to marketed Preminent reference formulation in Asian Indian and Japanese volunteers , when administered under fasting conditions .